// App-Quantinova.ai

4184 : Pre-clinical study using KRAS mutant mouse models for lung cancer immunotherapy together with MEK inhibition

Researchers

Presenter

  • Jiehui Deng

Principal Investigators

  • Shuai Li

  • Grit Herter-Sprie

  • Paul D. Smith

  • Gordon J. Freeman

  • Jeffrey A. Engelman

  • Peter Hammerman

  • Kwok-Kin Wong

Medical Centers

  • Dana-Farber Cancer Institute, Boston, MA

  • University of Cologne, Cologne, DE, Germany

  • Massachusetts General Hospital, Boston, MA

Locations

  • United States

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved